Updated results from MONALEESA-2, a phase 3 trial of first-line ribociclib + letrozole in hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC)
作者
Simon Spazzapan,PierFranco Conte,Edda Simoncini,Mario Campone,Michelle C. Miller,Gabe S. Sonke